Dihydrobiopterin (BH2): Key determinant in influencing arginine mediated endothelial tolerance and dysfunction

American Journal of Biochemistry and Biotechnology

Volumn 8, Issue 2, 2012, Pages 54-62

  Mohan, Srinidi ^a   Patel, Harsh ^a   Bolinaga, Jorge ^a   Soekamto, Nathania ^a   Achu, Lum ^a   Teklemariam, Kefali ^a  

^a UNIVERSITY OF NEW ENGLAND   (United States)

Author keywords

Arginine; Dihydrobiopterin; eNOS; Super oxide; Tetrahydrobiopterin

Indexed keywords

BINDING STUDIES; BIOPTERIN; CELL EXTRACTS; COFACTORS; DIHYDROBIOPTERIN; ELISA METHODS; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL NITRIC-OXIDE SYNTHASE (ENOS); ENOS; FLUORESCENCE TECHNIQUE; HPLC METHOD; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; IN-VITRO; ISOFORMS; KEY DETERMINANTS; L-ARGININE; MOLECULAR LINKS; OXIDATION PRODUCTS; PRODUCT FORMATION; SUPER-OXIDE; TETRAHYDROBIOPTERIN;

COENZYMES; ENDOTHELIAL CELLS; NITRIC OXIDE;

ARGININE;

ARGININE; BIOPTERIN; CELL EXTRACT; DIHYDROBIOPTERIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRATE; NITRIC OXIDE; NITRITE; OXYGEN;

ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; OXIDATION; OXIDATIVE STRESS; UMBILICAL VEIN ENDOTHELIAL CELL;

EID: 84862842924     PISSN: 15533468     EISSN: None     Source Type: Journal    
DOI: 10.3844/ajbb.2012.54.62     Document Type: Article

References (42)

1. Alp, N.J. and K.M. Channon, 2004. Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease. Arterioscler. Thromb. Vasc. Biol., 24: 413-420. DOI: 10.1161/ 01.ATV.0000110785.96039.f6
2. Bednarz, B., R. Wolk, T. Chamiec, K. Herbaczynska-Cedro and D. Winek et al., 2000. Effects of oral L-arginine supplementation on exercise-induced QT dispersion and exercise tolerance in stable angina pectoris. Int. J. Cardiol., 75: 205-210. DOI: 10.1016/S0167-5273(00)00324-7
3. Bednarz, B., T. Jaxa-Chamiec, J. Gebalska, K. Herbaczynska-Cedro and L. Ceremuzynski, 2004. L-arginine supplementation prolongs exercise capacity in congestive heart failure. Kardiol. Pol., 60: 348-353. PMID: 15226784
4. Bednarz, B., T. Jaxa-Chamiec, P. Maciejewski, M. Szpajer and K. Janik et al., 2005. Efficacy and safety of oral l-arginine in acute myocardial infarction. Results of the multicenter, randomized, double-blind, placebo-controlled ARAMI pilot trial. Kardiol. Pol., 62: 421-427. PMID: 15928719
5. Bitar, M.S., S. Wahid, S. Mustafa, E. Al-Saleh and G.S. Dhaunsi et al., 2005. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes. Eur. J. Pharmacol., 511: 53-64. DOI: 10.1016/j.ejphar.2005.01.014
6. Chen, J., P. Kuhlencordt, F. Urano, H. Ichinose and J. Astern et al., 2003. Effects of chronic treatment with L-arginine on atherosclerosis in apoE knockout and apoE/inducible NO synthase double-knockout mice. Arterioscler. Thromb. Vasc. Biol., 23: 97-103. DOI: 10.1161/01.ATV.0000040223.74255.5A
7. Gori, T., J.M. Burstein, S. Ahmed, S.E.S. Miner and A. Al-Hesayen et al., 2001. Folic acid prevents nitroglycerin-induced nitric oxide synthase dysfunction and nitrate tolerance: A human in vivo study. Circulation, 104: 1119-1123.
8. Gross, S.S., E.A. Jaffe, R. Levi and R.G. Kilbourn, 1991. Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophages. Biochem. Biophys. Res. Commun., 178: 823-829. DOI: 10.1016/0006-291X(91)90965-A
9. Ha, Y.H. and J.A. Milner, 1979. Urea cycle operation in the arginine deficient rat. Biochem. Med., 22: 149-155. DOI: 10.1016/0006-2944(79)90001-2
10. Heales, S. and K. Hyland, 1989. Determination of quinonoid dihydrobiopterin by high-performance liquid chromatography and electrochemical detection. J. Chromatography B: Biomed. Sci. Appli., 494: 77-85. DOI: 10.1016/S0378-4347(00)82658-4
11. Heitzer, T., K. Krohn, S. Albers and T. Meinertz, 2000. Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus. Diabetologia, 43: 1435-1438. DOI: 10.1007/s001250051551
12. Higashi, Y., S. Sasaki, K. Nakagawa, Y. Fukuda and H. Matsuura et al., 2002. Tetrahydrobiopterin enhances forearm vascular response to acetylcholine in both normotensive and hypertensive individuals. Am. J. Hypertension, 15: 326-332. DOI: 10.1016/S0895-7061(01)02317-2
13. Huang, H.S., M.C. Ma and J. Chen, 2008. Chronic L-arginine administration increases oxidative and nitrosative stress in rat hyperoxaluric kidneys and excessive crystal deposition. Am. J. Physiol. Renal Physiol., 295: F388-F396. DOI: 10.1152/ajprenal.00405.2007
14. Kwon, N.S., C.F. Nathan and D.J. Stuehr, 1989. Reduced biopterin as a cofactor in the generation of nitrogen oxides by murine macrophages. J. Biol. Chem., 264: 20496-20501. PMID: 2584226
15. Landmesser, U., S. Dikalov, S.R. Price, L. McCann and T. Fukai et al., 2003. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J. Clin. Investigat., 111: 1201-1209. DOI: 10.1172/JCI14172
16. Liu, P., C.E. Hock, R. Nagele and P.Y. Wong, 1997. Formation of nitric oxide, superoxide and peroxynitrite in myocardial ischemia-reperfusion injury in rats. Am. J. Physiol., 272: H2327-2336.
17. Lowry, O.H., N.J. Rosebrough, A.L. Farr and R.J. Randall, 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193: 265-275.
18. Mabile, L., O. Meilhac, I. Escargueil-Blanc, M. Troly and M.T. Pieraggi et al., 1997. Mitochondrial function is involved in LDL oxidation mediated by human cultured endothelial cells. Arterioscler. Thromb. Vasc. Biol., 17: 1575-1582. DOI: 10.1161/ 01.ATV.17.8.1575
19. Maxwell, A.J., M.P. Zapien, G.L. Pearce, G. MacCallum and P.H. Stone, 2002. Randomized trial of a medical food for the dietary management of chronic, stable angina. J. Am. College Cardiol., 39: 37-45. DOI: 10.1016/S0735-1097(01)01708-9
20. Mohan, S., C.C. Wu, S. Shin and H.L. Fung, 2011. Continuous exposure to L-arginine induces oxidative stress and physiological tolerance in cultured human endothelial cells. Amino Acids, DOI: 10.1007/s00726-011-1173-y
21. Nishikawa, T., D. Edelstein, X.L. Du, S. Yamagishi and T. Matsumura et al., 2000. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature, 404: 787-790. DOI: 10.1038/35008121
22. Oka, R.K., A. Szuba, J.C. Giacomini and J.P. Cooke, 2005. A pilot study of L-arginine supplementation on functional capacity in peripheral arterial disease. Vasc. Med., 10: 265-274. DOI: 10.1191/1358863x05vm637oa
23. Pieper, G.M., M. Jordan, L. A. Dondlinger, M.B. Adams and A.M. Roza, 1995. Peroxidative stress in diabetic blood vessels. Reversal by pancreatic islet transplantation. Diabetes, 44: 884-889. PMID: 7621992
24. Popovic, P.J., H.J. Zeh and J.B. Ochoa, 2007. Arginine and Immunity. J Nutr., 137: 1681S-1686S.
25. Romero, J.R., S.M. Suzuka, R.L. Nagel and M.E. Fabry, 2002. Arginine supplementation of sickle transgenic mice reduces red cell density and Gardos channel activity. Blood, 99: 1103-1108. DOI: 10.1182/blood.V99.4.1103
26. Schmidt, T.S. and N.J. Alp, 2007. Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease. Clin. Sci., 113: 47-63. DOI: 10.1042/CS20070108
27. Schulman, S.P., L.C. Becker, D.A. Kass, H.C. Champion and M.L. Terrin et al., 2006. L-Arginine therapy in acute myocardial infarction the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical tria. J. Am. Med. Assoc., 295: 58-64. DOI: 10.1001/jama.295.1.58
28. Setoguchi, S., Y. Hirooka, K. Eshima, H. Shimokawa and A. Takeshita, 2002. Tetrahydrobiopterin improves impaired endothelium-dependent forearm vasodilation in patients with heart failure. J. Cardiovasc. Pharmacol., 39: 363-368. PMID: 11862115
29. Shinozaki, K., Y. Nishio, T. Okamura, Y. Yoshida and H. Maegawa et al., 2000. Oral administration of tetrahydrobiopterin prevents endothelial dysfunction and vascular oxidative stress in the aortas of insulin-resistant rats. Circ. Res., 87: 566-573. DOI: 10.1161/01.RES.87.7.566
30. Simonet, S., A. Rupin, C. Badier-Commander, S. Coumailleau and D. Behr-Roussel et al., 2004. Evidence for superoxide anion generation in aortas of cholesterol-fed rabbits treated with L-arginine. Eur. J. Pharmacol., 492: 211-216. DOI: 10.1016/j.ejphar.2004.03.052
31. Srinivasan, S., M.E. Hatley, D.T. Bolick, L.A. Palmer and D. Edelstein et al., 2004. Hyperglycaemia-induced superoxide production decreases eNOS expression via AP-1 activation in aortic endothelial cells. Diabetologia, 47: 1727-1734. DOI: 10.1007/s00125-004-1525-1
32. Stroes, E., J. Kastelein, F. Cosentino, W. Erkelens and R. Wever et al., 1997. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J. Clin. Investigat., 99: 41-46. DOI: 10.1172/JCI119131
33. Tayeh, M.A. and M.A. Marletta, 1989. Macrophage oxidation of L-arginine to nitric oxide, nitrite and nitrate. Tetrahydrobiopterin is required as a cofactor. J. Biol. Chem., 264: 19654-19658.
34. Tiefenbacher, C.P., W.M. Chilian, M. Mitchell and D.V. De Fily, 1996. Restoration of endothelium-dependent vasodilation after reperfusion injury by tetrahydrobiopterin. Circulation, 94: 1423-1429. DOI: 10.1161/01.CIR.94.6.1423
35. Veresh, Z., A. Racz, G. Lotz and A. Koller, 2008. ADMA impairs nitric oxide-mediated arteriolar function due to increased superoxide production by angiotensin II-NAD(P)H oxidase pathway. Hypertension, 52: 960-966. DOI: 10.1161/ HYPERTENSIONAHA.108.116731
36. Vichinsky, E., 2002. New therapies in sickle cell disease. Lancet, 360: 629-631.
37. Wilson, A.M., R. Harada, N. Nair, N. Balasubramanian and J.P. Cooke, 2007. L-arginine supplementation in peripheral arterial disease: No benefit and possible harm. Circulation, 116: 188-195. DOI: 10.1161/CIRCULATIONAHA.106.683656
38. Wolff, D.J., G.A. Datto and R.A. Samatovicz, 1993. The dual mode of inhibition of calmodulin-dependent nitric-oxide synthase by antifungal imidazole agents. J. Biol. Chem., 268: 9430-9436.
39. Wu, G. and S.M. Morris Jr., 1998. Arginine metabolism: nitric oxide and beyond. Biochem. J., 336: 1-17.
40. Yoshida, A., N. Pozdnyakov, L. Dang, S.M. Orselli and V.N. Reddy et al., 1995. Nitric oxide synthesis in retinal photoreceptor cells. Visual Neurosci., 12: 493-500. DOI: 10.1017/S0952523800008397
41. Zhao, H., S. Kalivendi, H. Zhang, J. Joseph and K. Nithipatikom et al., 2003. Superoxide reacts with hydroethidine but forms a fluorescent product that is distinctly different from ethidium: Potential implications in intracellular fluorescence detection of superoxide. Free Radical Biol. Med., 34: 1359-1368. DOI: 10.1016/S0891-5849(03)00142-4
42. Zhou, M. and R.G. Martindale, 2007. Arginine in the critical care setting. J. Nutr., 137: 1687S-1692S.